A Study to Evaluate the Efficacy and Safety of AD-224 — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study to Evaluate the Efficacy and Safety of AD-224 — Stella

Home/Hypertension,Essential/

View on ClinicalTrials.gov

Recruiting

Back to Hypertension,Essential trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

South Korea

Seoul National University Bundang Hospital, Seongnam-si

Key details

Phase

Large-scale testing

Sponsor

Addpharma Inc.

Enrollment target

~252 participants

Started

April 2024

Primary completion

July 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

19 Years and older

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.